SGCD p.Ala239Val
c.716C>T · rs377153196 · VCV352336
Computational evidence
| Protein change | ||
| AlphaMissense | 0.122 | likely benign |
|---|---|---|
| REVEL | 0.391 | indeterminate |
| SaProt | LLR -8.29 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | Δ0.22 | acceptor loss, 16 bp away · masked 0 · deltas |
| Constraint at this position | ||
| Conservation | phyloP 6 | GERP 0.74, phastCons 1 |
| Regional constraint | o/e 1.12 | unconstrained · MANE · 430 kb · p 0.031 · regional, not allelic |
| Overall | ||
| CADD | 24.0 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM A238V vs ClinVar A239V) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Ashkenazi Jewishnot grpmax-eligible | 0.0574% | 1,741 |
| East Asiangrpmax | 0.0111% | 8,976 |
| Remaining individualsnot grpmax-eligible | 0.0032% | 31,226 |
| European (non-Finnish) | 0.00212% | 47,183 |
Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- SGCD
- Protein
- p.Ala239Val
- Coding
- c.716C>T
- MANE Select
- NM_000337
- dbSNP
- rs377153196
- Type
- single nucleotide variant
- Location
- chr5:156759233 (GRCh38)
- Gene constraint
- LOEUF 0.88 · pLI 0.05 (gnomAD)
- Structure
- AlphaFold pLDDT 81.43
Disease context
dilated cardiomyopathy 1L — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: autosomal recessive limb-girdle muscular dystrophy type 2Fqualitative or quantitative defects of delta-sarcoglycan
For Familial isolated dilated cardiomyopathy (Orphanet):
- Inheritance
- Autosomal dominant, Autosomal recessive, Mitochondrial inheritance
- Onset
- All ages
- Prevalence
- 1-9 / 100 000 (Europe)
Similar variants
- SGCD p.Ala239= Conflicting classifications of pathogenicity ★ same residue
- SGCD p.Ala239Thr Uncertain significance ★ ⚠ same residue
- SGCD p.Arg165Ter Pathogenic ★★★ same condition
- SGCD p.Arg97Ter Pathogenic ★★★ same condition
- SGCD p.Arg31Trp Uncertain significance ★★★ ⚠ same condition
- SGCD p.Ile64Thr Uncertain significance ★★★ ⚠ same condition
- SGCD c.192+1G>A Likely pathogenic ★★ same condition
- SGCD c.294+1G>A Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sgcd-p-ala239val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown